Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response

Human Pathology

Volumn 38, Issue 12, 2007, Pages 1798-1809

  Verine, Jérôme ^a,b,c   Mourad, Nathalie ^a   Desseaux, Kristell ^a   Vanhille, Philippe ^d   Noël, Laure Hélène ^e   Beaufils, Hélène ^f   Grateau, Gilles ^g   Janin, Anne ^a,b,c   Droz, Dominique ^a,c  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d CENTRE HOSPITALIER DE VALENCIENNES   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HÔPITAL TENON   (France)

Author keywords

AA amyloidosis; Glomerular crescents; Histological forms; Inflammatory reaction; Kidney

Indexed keywords

AMYLOID A PROTEIN; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL FEATURE; COMPLEMENT FACTOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC DISORDER; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INFLAMMATORY INFILTRATE; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MESANGIUM; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PROTEINURIA; RETROSPECTIVE STUDY; TUMOR;

ADULT; AGED; AMYLOIDOSIS; FEMALE; HEMATURIA; HUMANS; HYPERTENSION; INFLAMMATION; KIDNEY DISEASES; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN;

EID: 36549082805     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.04.013     Document Type: Article

References (32)

1. Röcken C., and Sletten K. Amyloid in surgical pathology. Virchows Arch 443 (2003) 3-16
2. Westermark P., Sletten K., and Eriksson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab Invest 41 (1979) 427-431
3. Falck H.M., Törnroth T., and Wegelius O. Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria. Clin Nephrol 19 (1983) 137-142
4. Looi L.M. Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism. Histopathology 14 (1989) 111-120
5. Uda H., Yokota A., Kobayashi K., et al. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol 33 (2006) 1482-1487
6. Scolding N.J., Joseph F., Kirby P.A., et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128 (2005) 500-515
7. Argiles A., Garcia Garcia M., and Mourad G. Phagocytosis of dialysis-related amyloid deposits by macrophages. Nephrol Dial Transplant 17 (2002) 1136-1138
8. Watanabe T., and Saniter T. Morphological and clinical features of renal amyloidosis. Virchows Arch A Pathol Anat Histol 366 (1975) 125-135
9. Shiiki H., Shimokama T., Yoshikawa Y., et al. Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features. Virchows Arch A Pathol Anat Histopathol 412 (1988) 197-204
10. Racusen L.C., Solez K., Colvin R.B., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 55 (1999) 713-723
11. Larvol L., Cervoni J.P., Besnier M., et al. Reversible nephrotic syndrome in Crohn's disease complicated with renal amyloidosis. Gastroenterol Clin Biol 22 (1998) 639-641
12. Sbai A., Wechsler B., Leenhardt L., et al. Amyloid goiter as the initial manifestation of systemic amyloidosis due to familial Mediterranean fever with homozygous MEFV mutation. Thyroid 11 (2001) 397-400
13. Hazenberg B.P., and van Rijswijk M.H. Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8 (1994) 661-690
14. Gertz M.A., and Kyle R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70 (1991) 246-256
15. Janssen S., Van Rijswijk M.H., Meijer S., et al. Systemic amyloidosis: a clinical survey of 144 cases. Neth J Med 29 (1986) 376-385
16. Westermark P. Aspects on human amyloid forms and their fibril polypeptides. FEBS J 272 (2005) 5942-5949
17. Grateau G., Jeru I., Rouaghe S., et al. Amyloidosis and auto-inflammatory syndromes. Curr Drug Targets Inflamm Allergy 4 (2005) 57-65
18. Nakamura T., Higashi S., Tomoda K., et al. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology 45 (2006) 43-49
19. Weiss S.W., and Page D.L. Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells. Am J Pathol 72 (1973) 447-460
20. Martinez Cabruja R., Fernandez Segoviano P., Ulloa Garcia J., et al. Giant cells in the glomerulus and renal amyloid. Report of a case. Med Clin (Barc) 73 (1979) 347-349
21. Sidoni A., Alberti P.F., Bravi S., et al. Amyloid tumours in the soft tissues of the legs. Case report and review of the literature. Virchows Arch 432 (1998) 563-566
22. Nagata M., Shimokama T., Harada A., et al. Glomerular crescents in renal amyloidosis: an epiphenomenon or distinct pathology?. Pathol Int 51 (2001) 179-186
23. Schafernak K.T., Chugh S.S., and Kanwar Y.S. Co-existent crescentic glomerulonephritis and renal amyloidosis: a case report and literature review. J Nephrol 18 (2005) 616-622
24. Kluve-Beckerman B., Manaloor J.J., and Liepnieks J.J. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum 46 (2002) 1905-1913
25. Rocken C., Menard R., Buhling F., et al. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 64 (2005) 808-815
26. Shimojima Y., Takei Y., Tazawa K., et al. Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman's disease. Amyloid 13 (2006) 184-186
27. Kebbel A., and Röcken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30 (2006) 673-683
28. Hrncic R., Wall J., Wolfenbarger D.A., et al. Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol 157 (2000) 1239-1246
29. Solomon A., Weiss D.T., and Wall J.S. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin Cancer Res 9 (2003) 3831S-3838S
30. O'Nuallain B., Hrncic R., Wall J.S., et al. Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera. J Immunol 176 (2006) 7071-7078
31. Rocken C., Fandrich M., Stix B., et al. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. J Pathol 210 (2006) 478-487
32. Thomas G.J., and Davies M. The potential role of human kidney cortex cysteine proteinases in glomerular basement membrane degradation. Biochim Biophys Acta 990 (1989) 246-253